An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
Study Number: 

PH 274315

Phase: 
3
Trial categories: 
Acute Myeloid Leukemia (AML)
Leukemia
Principal Investigator: